lipids

Should we aggressively lower serum cholesterol in people with non-atherosclerotic stroke? 3:55
Should we aggressively lower serum cholesterol in people with non-atherosclerotic stroke?
Hrvoje Budincevic • 30 Mar 2023
Lipid-based therapies for MS 2:13
Lipid-based therapies for MS
Gesine Saher • 4 Nov 2022
Lipids in MS: future research & treatment approaches 2:58
Lipids in MS: future research & treatment approaches
Gesine Saher • 4 Nov 2022
Lipid-dependent processes within CNS demyelination and remyelination 8:02
Lipid-dependent processes within CNS demyelination and remyelination
Gesine Saher • 31 Oct 2022
The importance of cholesterol synthesis in acute demyelination 3:38
The importance of cholesterol synthesis in acute demyelination
Gesine Saher • 31 Oct 2022
Protective and pro-inflammatory lipid mediators in MS 1:22
Protective and pro-inflammatory lipid mediators in MS
Gijs Kooij • 27 Oct 2022
Lipids: a two-fold approach in multiple sclerosis 1:47
Lipids: a two-fold approach in multiple sclerosis
Gijs Kooij • 27 Oct 2022
Epigenetic mechanisms of lipid mediators in multiple sclerosis 0:39
Epigenetic mechanisms of lipid mediators in multiple sclerosis
Gijs Kooij • 27 Oct 2022
The current and future scope of α-synuclein research 1:45
The current and future scope of α-synuclein research
Tiago Outeiro • 17 Sep 2022
Lipidomic approaches identify Parkinson’s disease-specific lipid signatures 2:39
Lipidomic approaches identify Parkinson’s disease-specific lipid signatures
Serge Przedborski • 16 Sep 2022
α-Synuclein research: insightful discoveries in cell biology 1:56
α-Synuclein research: insightful discoveries in cell biology
Tiago Outeiro • 17 Sep 2022
The role of lipid metabolism in Parkinson’s disease 2:18
The role of lipid metabolism in Parkinson’s disease
Serge Przedborski • 16 Sep 2022
Future migraine biomarkers research: lipids 0:56
Future migraine biomarkers research: lipids
Gisela Terwindt • 1 Sep 2021
The content of VJNeurology is intended for healthcare professionals